H. He

Successful management of lung adenocarcinoma with ALK/EGFR co-alterations and PD-L1 over-expression by bevacizumab combined with chemotherapy

Zhenzhou Yang, Yuan Peng, Wendi Yang, 2021, Angiogenesis.

Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer

J. Bai, Songbin Fu, Wenjing Sun, 2017, Oncotarget.